Concepedia

Author

Marie Luisa Schmidt

Charité - Universitätsmedizin BerlinORCID

Also Known As

M Schmidt, M. Schmidt, Marie L Schmidt, Marie L. Schmidt, Marie Luisa Schmidt, Schmidt, Marie, Terry C. Jones

50

Publications

10.6K

Citations

19

H-Index

64

Concepts

All Affiliations

Charité - Universitätsmedizin BerlinFreie Universität BerlinHumboldt-Universität zu BerlinGerman Center for Infection ResearchFriedrich-Loeffler-Institut
ML

About

Marie Luisa Schmidt is an author at Charité - Universitätsmedizin Berlin specializing in medicine, virology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

15

882

2

Public Health

2

2

108

3

Cell Biology

2

2

69

4

Engineering

1

1

16

5

Biomolecular Engineering

1

1

16

Marie Luisa Schmidt

×

27

Publications

10.6K

Citations

19

H-Index

YearCitations

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman, Olfert Landt, Marco Kaiser,

Eurosurveillance

2020

8.1K

Estimating infectiousness throughout SARS-CoV-2 infection course

Terry C. Jones, Guido Biele, Barbara Mühlemann,

Science

2021

521

A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model

Jakob Kreye, S. Momsen Reincke, Hans‐Christian Kornau,

Cell

2020

380

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

David Hillus, Tatjana Schwarz, Pinkus Tober‐Lau,

The Lancet Respiratory Medicine

2021

352

Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study

Victor M. Corman, Verena Haage, Tobias Bleicker,

The Lancet Microbe

2021

338

Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta

Lorenz Ulrich, Nico Joël Halwe, Adriano Taddeo,

Nature

2021

109

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

N. Ahmad Aziz, Victor M. Corman, Antje K. C. Echterhoff,

Nature Communications

2021

99

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

S. Momsen Reincke, Meng Yuan, Hans‐Christian Kornau,

Science

2022

89

Comparison of seven commercial SARS-CoV-2 rapid Point-of-Care Antigen tests

Victor M. Corman, Verena Haage, Tobias Bleicker,

2020

78

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1-nCoV19 and BNT162b2: a prospective cohort study

David Hillus, Tatjana Schwarz, Pinkus Tober‐Lau,

2021

73

Page 1